Meet the Class of 2027

Three people giving the Hook 'em Horns hand gesture and holding a "Future Pharm.D." banner.
January 16, 2024
Get to know some of Texas Pharmacy's P1 students. We caught up with P1 Pharm.D. students Thomas, Seun, Marissa, Kayla, Kimberly, Paul and Princy to see how first year is going one semester in, what makes them excited about Texas Pharmacy and becoming a future Longhorn pharmacist and how they unwind after a long day of classes and studying.

Meet the Class of 2026

A group of pharmacy students pose together during the Class of 2026 Block party celebration.
November 16, 2022
Get to know some of Texas Pharmacy's P1 students.

Faculty Earn State Grants for Cancer Research

A person in a lab.
September 21, 2022
The Cancer Prevention and Research Institute of Texas (CPRIT) has released its grant research funding awards for the upcoming year. All three awarded research projects at The University of Texas at Austin involve College of Pharmacy faculty.

Pharmacy Students Report Both Motivators, Barriers to Attending Class Pre-, Post-Pandemic

Pie charts.
December 7, 2021
Student pharmacist Cara Rutledge (Pharm.D. Class of 2022) wrote an article for the Pharmacy Times about her honors program thesis which aimed to address the various complexities of student motivation, engagement and attendance in relation to mastery of course material.

UT Pharmacy Students Reflect on the Pandemic, Look to the Future

A person typing on a laptop in their house.
December 1, 2021
UT student pharmacists Kailee Marikar, Sadaf Helforoosh, Hannah McCullough, Agaustin Wong and Cara Rutledge talked to the Pharmacy Times’ Skylar Kenney about their experiences balancing their studies in the midst of the pandemic and how COVID-19 showed a pharmacist's vital role in public health.

Immunologic Resilience: A New Metric to Accurately Gauge COVID-19’s Path

The COVID-19 virus.
September 8, 2021
UT Pharmacy and UT Health Science Center San Antonio Assistant Professor Grace C. Lee, Pharm.D., Ph.D. is the first author of a recently published study that unveiled a novel concept, “immunologic resilience,” to accurately predict which COVID-19 patients will advance to severe disease and which will not.